NASDAQ | DRNA

$9.54 + 0.06 (+0.633%)

3 month stock price graph

4:00 PM ET on Nov 17, 2017 Pricing delayed 20 minutes

Investors & Media

Download Library

 
Download Library
Date Document Type
Nov 15, 2017 Dicerna Pharmaceuticals Corporate Overview
Presentations
Oct 26, 2017 GalXC TM RNAi Platform Enables Potent and Durable RNAi-Mediated Inhibition of Hepatitis B Virus in Preclinical Models
Presentations
Sep 25, 2017 Rodman & Renshaw 19th Annual Global Investment Conference Presentation
Presentations
Jul 15, 2017 DCR-PHXC:A new approach for treating all Primary Hyperoxalurias by inhibiting LDHA
Presentations
Jul 14, 2017 Oxalate Production in Primary Hyperoxaluria Types 1, 2 and 3 and the Role of LDH in the Liver
Presentations
Jul 14, 2017 PHYOS: An Observational Study of Patients with Primary Hyperoxaluria Type 1
Presentations
Jun 9, 2017 Jefferies 2017 Global Healthcare Conference Presentation
Presentations
May 15, 2017 Dicerna US Tides May 2017 Presentation
Presentations
Apr 17, 2017 GalXC cGMP Manufacturing Experience Presentation
Presentations
April 7, 2017 BioCentury 24th Annual Future Leaders in the Biotech Industry Conference
Presentations
Page:
1
NextLast
= add file to Briefcase